Skip to content
20-F

Annual Report (Foreign)

CORDOVACANN CORP. LVRLF

0001654954-23-016056

← back to feed
Filed
Dec 28, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 30, 2023 109.5M sh
Cash And Equivalents FY 2023 · Jun 30, 2022 714.83K
Current Liabilities FY 2023 · Jun 30, 2022 5.7M
Total Liabilities FY 2023 · Jun 30, 2022 10.16M
Current Assets FY 2023 · Jun 30, 2022 3.21M
Total Assets FY 2023 · Jun 30, 2022 16.75M
Operating Cash Flow FY 2023 · Jun 30, 2021 −221.16K
Net Income FY 2023 · Jun 30, 2021 −4.79M
Gross Profit FY 2023 · Jun 30, 2021 3.49M
Cost Of Revenue restated FY 2023 · Jun 30, 2021 6.83M
Revenue FY 2023 · Jun 30, 2021 10.32M
Stockholders Equity FY 2023 · Jun 30, 2020 6.28M